The negative prognostic impact of bone metastasis with a tumor mass
OBJECTIVE:Typically, bone metastasis causes osteolytic and osteoblastic lesions resulting from the interactions of tumor cells with osteoclasts and osteoblasts. In addition to these interactions, tumor tissues may grow inside bones and cause mass lesions. In the present study, we aimed to demonstrat...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2015-08-01
|
| Series: | Clinics |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000800535&lng=en&tlng=en |
| _version_ | 1818245696564756480 |
|---|---|
| author | Birsen Yücel Mustafa Gürol Celasun Bilge Öztoprak Zekiye Hasbek Seher Bahar Turgut Kaçan Aykut Bahçeci Mehmet Metin Şeker |
| author_facet | Birsen Yücel Mustafa Gürol Celasun Bilge Öztoprak Zekiye Hasbek Seher Bahar Turgut Kaçan Aykut Bahçeci Mehmet Metin Şeker |
| author_sort | Birsen Yücel |
| collection | DOAJ |
| description | OBJECTIVE:Typically, bone metastasis causes osteolytic and osteoblastic lesions resulting from the interactions of tumor cells with osteoclasts and osteoblasts. In addition to these interactions, tumor tissues may grow inside bones and cause mass lesions. In the present study, we aimed to demonstrate the negative impact of a tumor mass in a large cohort of patients with bone metastatic cancer.METHODS:Data from 335 patients with bone metastases were retrospectively reviewed. For the analysis, all patients were divided into three subgroups with respect to the type of bone metastasis: osteolytic, osteoblastic, or mixed. The patients were subsequently categorized as having bone metastasis with or without a tumor mass, and statistically significant differences in median survival and 2-year overall survival were observed between these patients (the median survival and 2-year overall survival were respectively 3 months and 16% in patients with a tumor mass and 11 months and 26% in patients without a tumor mass; p<0.001).RESULTS:According to multivariate analysis, the presence of bone metastasis with a tumor mass was found to be an independent prognostic factor (p=0.011, hazard ratio: 1.62, 95% confidence interval: 1.11–1.76). Bone metastasis with a tumor mass was more strongly associated with osteolytic lesions, other primary diseases (except for primary breast and prostate cancers), and spinal cord compression.CONCLUSION:Bone metastasis with a tumor mass is a strong and independent negative prognostic factor for survival in cancer patients. |
| first_indexed | 2024-12-12T14:37:01Z |
| format | Article |
| id | doaj.art-56894d27086b45db87a1a04ab5388604 |
| institution | Directory Open Access Journal |
| issn | 1980-5322 |
| language | English |
| last_indexed | 2024-12-12T14:37:01Z |
| publishDate | 2015-08-01 |
| publisher | Elsevier España |
| record_format | Article |
| series | Clinics |
| spelling | doaj.art-56894d27086b45db87a1a04ab53886042022-12-22T00:21:22ZengElsevier EspañaClinics1980-53222015-08-0170853554010.6061/clinics/2015(08)01S1807-59322015000800535The negative prognostic impact of bone metastasis with a tumor massBirsen YücelMustafa Gürol CelasunBilge ÖztoprakZekiye HasbekSeher BaharTurgut KaçanAykut BahçeciMehmet Metin ŞekerOBJECTIVE:Typically, bone metastasis causes osteolytic and osteoblastic lesions resulting from the interactions of tumor cells with osteoclasts and osteoblasts. In addition to these interactions, tumor tissues may grow inside bones and cause mass lesions. In the present study, we aimed to demonstrate the negative impact of a tumor mass in a large cohort of patients with bone metastatic cancer.METHODS:Data from 335 patients with bone metastases were retrospectively reviewed. For the analysis, all patients were divided into three subgroups with respect to the type of bone metastasis: osteolytic, osteoblastic, or mixed. The patients were subsequently categorized as having bone metastasis with or without a tumor mass, and statistically significant differences in median survival and 2-year overall survival were observed between these patients (the median survival and 2-year overall survival were respectively 3 months and 16% in patients with a tumor mass and 11 months and 26% in patients without a tumor mass; p<0.001).RESULTS:According to multivariate analysis, the presence of bone metastasis with a tumor mass was found to be an independent prognostic factor (p=0.011, hazard ratio: 1.62, 95% confidence interval: 1.11–1.76). Bone metastasis with a tumor mass was more strongly associated with osteolytic lesions, other primary diseases (except for primary breast and prostate cancers), and spinal cord compression.CONCLUSION:Bone metastasis with a tumor mass is a strong and independent negative prognostic factor for survival in cancer patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000800535&lng=en&tlng=enBone metastasisBone metastasis with a tumor massPrognostic factorSurvival |
| spellingShingle | Birsen Yücel Mustafa Gürol Celasun Bilge Öztoprak Zekiye Hasbek Seher Bahar Turgut Kaçan Aykut Bahçeci Mehmet Metin Şeker The negative prognostic impact of bone metastasis with a tumor mass Clinics Bone metastasis Bone metastasis with a tumor mass Prognostic factor Survival |
| title | The negative prognostic impact of bone metastasis with a tumor mass |
| title_full | The negative prognostic impact of bone metastasis with a tumor mass |
| title_fullStr | The negative prognostic impact of bone metastasis with a tumor mass |
| title_full_unstemmed | The negative prognostic impact of bone metastasis with a tumor mass |
| title_short | The negative prognostic impact of bone metastasis with a tumor mass |
| title_sort | negative prognostic impact of bone metastasis with a tumor mass |
| topic | Bone metastasis Bone metastasis with a tumor mass Prognostic factor Survival |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000800535&lng=en&tlng=en |
| work_keys_str_mv | AT birsenyucel thenegativeprognosticimpactofbonemetastasiswithatumormass AT mustafagurolcelasun thenegativeprognosticimpactofbonemetastasiswithatumormass AT bilgeoztoprak thenegativeprognosticimpactofbonemetastasiswithatumormass AT zekiyehasbek thenegativeprognosticimpactofbonemetastasiswithatumormass AT seherbahar thenegativeprognosticimpactofbonemetastasiswithatumormass AT turgutkacan thenegativeprognosticimpactofbonemetastasiswithatumormass AT aykutbahceci thenegativeprognosticimpactofbonemetastasiswithatumormass AT mehmetmetinseker thenegativeprognosticimpactofbonemetastasiswithatumormass AT birsenyucel negativeprognosticimpactofbonemetastasiswithatumormass AT mustafagurolcelasun negativeprognosticimpactofbonemetastasiswithatumormass AT bilgeoztoprak negativeprognosticimpactofbonemetastasiswithatumormass AT zekiyehasbek negativeprognosticimpactofbonemetastasiswithatumormass AT seherbahar negativeprognosticimpactofbonemetastasiswithatumormass AT turgutkacan negativeprognosticimpactofbonemetastasiswithatumormass AT aykutbahceci negativeprognosticimpactofbonemetastasiswithatumormass AT mehmetmetinseker negativeprognosticimpactofbonemetastasiswithatumormass |